nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0237	0.0331	CbGbCtD
Nicardipine—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0223	0.0311	CbGbCtD
Nicardipine—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0223	0.0311	CbGbCtD
Nicardipine—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0201	0.0282	CbGbCtD
Nicardipine—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0175	0.0245	CbGbCtD
Nicardipine—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0169	0.0236	CbGbCtD
Nicardipine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0159	0.0222	CbGbCtD
Nicardipine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0159	0.0222	CbGbCtD
Nicardipine—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0155	0.0216	CbGbCtD
Nicardipine—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0153	0.0213	CbGbCtD
Nicardipine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0153	0.0213	CbGbCtD
Nicardipine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0153	0.0213	CbGbCtD
Nicardipine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0151	0.021	CbGbCtD
Nicardipine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0142	0.0198	CbGbCtD
Nicardipine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0137	0.0191	CbGbCtD
Nicardipine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0133	0.0186	CbGbCtD
Nicardipine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0128	0.0179	CbGbCtD
Nicardipine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0128	0.0179	CbGbCtD
Nicardipine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0125	0.0175	CbGbCtD
Nicardipine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.012	0.0168	CbGbCtD
Nicardipine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.012	0.0168	CbGbCtD
Nicardipine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0118	0.0164	CbGbCtD
Nicardipine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0118	0.0164	CbGbCtD
Nicardipine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0116	0.0162	CbGbCtD
Nicardipine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0116	0.0162	CbGbCtD
Nicardipine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0114	0.016	CbGbCtD
Nicardipine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0114	0.016	CbGbCtD
Nicardipine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0111	0.0155	CbGbCtD
Nicardipine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.011	0.0154	CbGbCtD
Nicardipine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0108	0.015	CbGbCtD
Nicardipine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0108	0.015	CbGbCtD
Nicardipine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0107	0.015	CbGbCtD
Nicardipine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0106	0.0149	CbGbCtD
Nicardipine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0106	0.0149	CbGbCtD
Nicardipine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0103	0.0144	CbGbCtD
Nicardipine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00973	0.0136	CbGbCtD
Nicardipine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00973	0.0136	CbGbCtD
Nicardipine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0097	0.0136	CbGbCtD
Nicardipine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0097	0.0136	CbGbCtD
Nicardipine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0093	0.013	CbGbCtD
Nicardipine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00919	0.0128	CbGbCtD
Nicardipine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00892	0.0125	CbGbCtD
Nicardipine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00891	0.0125	CbGbCtD
Nicardipine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00865	0.0121	CbGbCtD
Nicardipine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0084	0.0117	CbGbCtD
Nicardipine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00815	0.0114	CbGbCtD
Nicardipine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00806	0.0113	CbGbCtD
Nicardipine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00806	0.0113	CbGbCtD
Nicardipine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00783	0.0109	CbGbCtD
Nicardipine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00783	0.0109	CbGbCtD
Nicardipine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00773	0.0108	CbGbCtD
Nicardipine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0075	0.0105	CbGbCtD
Nicardipine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00737	0.0103	CbGbCtD
Nicardipine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00737	0.0103	CbGbCtD
Nicardipine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00728	0.0102	CbGbCtD
Nicardipine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00684	0.00957	CbGbCtD
Nicardipine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00684	0.00957	CbGbCtD
Nicardipine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00619	0.00865	CbGbCtD
Nicardipine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00619	0.00865	CbGbCtD
Nicardipine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0058	0.00811	CbGbCtD
Nicardipine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00534	0.00747	CbGbCtD
Nicardipine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00518	0.00725	CbGbCtD
Nicardipine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00469	0.00656	CbGbCtD
Nicardipine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00469	0.00656	CbGbCtD
Nicardipine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0045	0.00629	CbGbCtD
Nicardipine—CALM2—semen—acquired immunodeficiency syndrome	0.00262	0.0359	CbGeAlD
Nicardipine—CALM1—semen—acquired immunodeficiency syndrome	0.00261	0.0357	CbGeAlD
Nicardipine—CALM2—nerve—acquired immunodeficiency syndrome	0.00126	0.0173	CbGeAlD
Nicardipine—CALM1—nerve—acquired immunodeficiency syndrome	0.00126	0.0172	CbGeAlD
Nicardipine—CALM2—endothelium—acquired immunodeficiency syndrome	0.00108	0.0147	CbGeAlD
Nicardipine—CALM1—endothelium—acquired immunodeficiency syndrome	0.00107	0.0147	CbGeAlD
Nicardipine—PDE1B—blood—acquired immunodeficiency syndrome	0.00107	0.0146	CbGeAlD
Nicardipine—CACNB2—retina—acquired immunodeficiency syndrome	0.000986	0.0135	CbGeAlD
Nicardipine—CALM2—blood plasma—acquired immunodeficiency syndrome	0.000955	0.0131	CbGeAlD
Nicardipine—CALM1—blood plasma—acquired immunodeficiency syndrome	0.000951	0.013	CbGeAlD
Nicardipine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000907	0.0124	CbGeAlD
Nicardipine—PDE1B—nervous system—acquired immunodeficiency syndrome	0.000867	0.0119	CbGeAlD
Nicardipine—PDE1A—spinal cord—acquired immunodeficiency syndrome	0.000862	0.0118	CbGeAlD
Nicardipine—CHRM5—skin of body—acquired immunodeficiency syndrome	0.000839	0.0115	CbGeAlD
Nicardipine—PDE1B—central nervous system—acquired immunodeficiency syndrome	0.000834	0.0114	CbGeAlD
Nicardipine—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000792	0.0108	CbGeAlD
Nicardipine—PDE1A—lung—acquired immunodeficiency syndrome	0.000784	0.0107	CbGeAlD
Nicardipine—PDE1A—nervous system—acquired immunodeficiency syndrome	0.000726	0.00994	CbGeAlD
Nicardipine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000715	0.00978	CbGeAlD
Nicardipine—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.00071	0.00972	CbGeAlD
Nicardipine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000703	0.00963	CbGeAlD
Nicardipine—PDE1A—central nervous system—acquired immunodeficiency syndrome	0.000699	0.00957	CbGeAlD
Nicardipine—CACNB2—digestive system—acquired immunodeficiency syndrome	0.000692	0.00948	CbGeAlD
Nicardipine—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000667	0.00913	CbGeAlD
Nicardipine—CALM3—retina—acquired immunodeficiency syndrome	0.000666	0.00912	CbGeAlD
Nicardipine—CHRM4—nervous system—acquired immunodeficiency syndrome	0.000664	0.00909	CbGeAlD
Nicardipine—PDE1B—brain—acquired immunodeficiency syndrome	0.000662	0.00907	CbGeAlD
Nicardipine—PDE1B—lymph node—acquired immunodeficiency syndrome	0.00064	0.00876	CbGeAlD
Nicardipine—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.000639	0.00876	CbGeAlD
Nicardipine—CACNB2—vagina—acquired immunodeficiency syndrome	0.000611	0.00837	CbGeAlD
Nicardipine—CACNA2D1—bone marrow—acquired immunodeficiency syndrome	0.000599	0.00821	CbGeAlD
Nicardipine—CACNB2—lung—acquired immunodeficiency syndrome	0.000578	0.00792	CbGeAlD
Nicardipine—CACNA2D1—vagina—acquired immunodeficiency syndrome	0.000574	0.00786	CbGeAlD
Nicardipine—CACNA1C—digestive system—acquired immunodeficiency syndrome	0.000559	0.00765	CbGeAlD
Nicardipine—PDE1A—brain—acquired immunodeficiency syndrome	0.000555	0.0076	CbGeAlD
Nicardipine—CACNA2D1—lung—acquired immunodeficiency syndrome	0.000543	0.00743	CbGeAlD
Nicardipine—PDE1A—lymph node—acquired immunodeficiency syndrome	0.000536	0.00734	CbGeAlD
Nicardipine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000536	0.00734	CbGeAlD
Nicardipine—CACNB2—nervous system—acquired immunodeficiency syndrome	0.000535	0.00733	CbGeAlD
Nicardipine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000528	0.00723	CbGeAlD
Nicardipine—CALM2—retina—acquired immunodeficiency syndrome	0.000523	0.00716	CbGeAlD
Nicardipine—CALM1—retina—acquired immunodeficiency syndrome	0.000521	0.00713	CbGeAlD
Nicardipine—CHRM5—nervous system—acquired immunodeficiency syndrome	0.000519	0.00711	CbGeAlD
Nicardipine—CACNB2—central nervous system—acquired immunodeficiency syndrome	0.000515	0.00706	CbGeAlD
Nicardipine—CHRM4—brain—acquired immunodeficiency syndrome	0.000508	0.00695	CbGeAlD
Nicardipine—CACNA1D—lung—acquired immunodeficiency syndrome	0.000505	0.00692	CbGeAlD
Nicardipine—CACNA2D1—nervous system—acquired immunodeficiency syndrome	0.000503	0.00688	CbGeAlD
Nicardipine—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.0005	0.00684	CbGeAlD
Nicardipine—CACNA1C—vagina—acquired immunodeficiency syndrome	0.000493	0.00675	CbGeAlD
Nicardipine—CACNA2D1—central nervous system—acquired immunodeficiency syndrome	0.000484	0.00663	CbGeAlD
Nicardipine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000474	0.00649	CbGeAlD
Nicardipine—CACNA1D—nervous system—acquired immunodeficiency syndrome	0.000468	0.00641	CbGeAlD
Nicardipine—CACNA1C—lung—acquired immunodeficiency syndrome	0.000466	0.00639	CbGeAlD
Nicardipine—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.000464	0.00635	CbGeAlD
Nicardipine—CALM2—skin of body—acquired immunodeficiency syndrome	0.000459	0.00629	CbGeAlD
Nicardipine—CALM1—skin of body—acquired immunodeficiency syndrome	0.000457	0.00626	CbGeAlD
Nicardipine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000457	0.00625	CbGeAlD
Nicardipine—CACNA1D—central nervous system—acquired immunodeficiency syndrome	0.000451	0.00617	CbGeAlD
Nicardipine—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.000447	0.00612	CbGeAlD
Nicardipine—CALM3—blood—acquired immunodeficiency syndrome	0.000446	0.0061	CbGeAlD
Nicardipine—CACNA1C—nervous system—acquired immunodeficiency syndrome	0.000432	0.00591	CbGeAlD
Nicardipine—CALM3—bone marrow—acquired immunodeficiency syndrome	0.000431	0.0059	CbGeAlD
Nicardipine—CALM3—spinal cord—acquired immunodeficiency syndrome	0.000429	0.00588	CbGeAlD
Nicardipine—CACNA1C—central nervous system—acquired immunodeficiency syndrome	0.000416	0.00569	CbGeAlD
Nicardipine—CALM3—vagina—acquired immunodeficiency syndrome	0.000413	0.00566	CbGeAlD
Nicardipine—CACNB2—brain—acquired immunodeficiency syndrome	0.000409	0.0056	CbGeAlD
Nicardipine—CHRM5—brain—acquired immunodeficiency syndrome	0.000397	0.00543	CbGeAlD
Nicardipine—CACNB2—lymph node—acquired immunodeficiency syndrome	0.000395	0.00541	CbGeAlD
Nicardipine—CALM3—lung—acquired immunodeficiency syndrome	0.000391	0.00535	CbGeAlD
Nicardipine—CACNA2D1—brain—acquired immunodeficiency syndrome	0.000384	0.00526	CbGeAlD
Nicardipine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.00038	0.0052	CbGeAlD
Nicardipine—CHRM3—digestive system—acquired immunodeficiency syndrome	0.000375	0.00514	CbGeAlD
Nicardipine—CALM2—lymphoid tissue—acquired immunodeficiency syndrome	0.000372	0.00509	CbGeAlD
Nicardipine—CACNA2D1—lymph node—acquired immunodeficiency syndrome	0.000371	0.00508	CbGeAlD
Nicardipine—CALM1—lymphoid tissue—acquired immunodeficiency syndrome	0.00037	0.00507	CbGeAlD
Nicardipine—CALM2—digestive system—acquired immunodeficiency syndrome	0.000367	0.00503	CbGeAlD
Nicardipine—CALM1—digestive system—acquired immunodeficiency syndrome	0.000366	0.00501	CbGeAlD
Nicardipine—ADRA1B—brain—acquired immunodeficiency syndrome	0.000363	0.00496	CbGeAlD
Nicardipine—CACNA1D—brain—acquired immunodeficiency syndrome	0.000358	0.0049	CbGeAlD
Nicardipine—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000356	0.00488	CbGeAlD
Nicardipine—ADRA1D—brain—acquired immunodeficiency syndrome	0.000355	0.00486	CbGeAlD
Nicardipine—CHRM1—lung—acquired immunodeficiency syndrome	0.00035	0.0048	CbGeAlD
Nicardipine—CALM2—blood—acquired immunodeficiency syndrome	0.00035	0.00479	CbGeAlD
Nicardipine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000349	0.00478	CbGeAlD
Nicardipine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000349	0.00478	CbGeAlD
Nicardipine—CALM1—blood—acquired immunodeficiency syndrome	0.000348	0.00477	CbGeAlD
Nicardipine—CACNA1D—lymph node—acquired immunodeficiency syndrome	0.000346	0.00473	CbGeAlD
Nicardipine—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000343	0.0047	CbGeAlD
Nicardipine—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000341	0.00468	CbGeAlD
Nicardipine—CALM2—bone marrow—acquired immunodeficiency syndrome	0.000339	0.00464	CbGeAlD
Nicardipine—CALM2—spinal cord—acquired immunodeficiency syndrome	0.000337	0.00462	CbGeAlD
Nicardipine—CALM1—bone marrow—acquired immunodeficiency syndrome	0.000337	0.00462	CbGeAlD
Nicardipine—CALM1—spinal cord—acquired immunodeficiency syndrome	0.000336	0.0046	CbGeAlD
Nicardipine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000332	0.00455	CbGeAlD
Nicardipine—CACNA1C—brain—acquired immunodeficiency syndrome	0.00033	0.00452	CbGeAlD
Nicardipine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000328	0.00449	CbGeAlD
Nicardipine—CALM2—vagina—acquired immunodeficiency syndrome	0.000324	0.00444	CbGeAlD
Nicardipine—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000324	0.00444	CbGeAlD
Nicardipine—CALM1—vagina—acquired immunodeficiency syndrome	0.000323	0.00442	CbGeAlD
Nicardipine—CACNA1C—lymph node—acquired immunodeficiency syndrome	0.000319	0.00437	CbGeAlD
Nicardipine—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.000312	0.00428	CbGeAlD
Nicardipine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000308	0.00422	CbGeAlD
Nicardipine—CALM2—lung—acquired immunodeficiency syndrome	0.000307	0.0042	CbGeAlD
Nicardipine—CALM1—lung—acquired immunodeficiency syndrome	0.000305	0.00418	CbGeAlD
Nicardipine—CHRM3—nervous system—acquired immunodeficiency syndrome	0.00029	0.00397	CbGeAlD
Nicardipine—CYP2C8—blood—acquired immunodeficiency syndrome	0.00029	0.00397	CbGeAlD
Nicardipine—CALM2—nervous system—acquired immunodeficiency syndrome	0.000284	0.00389	CbGeAlD
Nicardipine—CALM1—nervous system—acquired immunodeficiency syndrome	0.000283	0.00387	CbGeAlD
Nicardipine—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.000279	0.00383	CbGeAlD
Nicardipine—CALM3—brain—acquired immunodeficiency syndrome	0.000277	0.00379	CbGeAlD
Nicardipine—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000277	0.00379	CbGeAlD
Nicardipine—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000275	0.00376	CbGeAlD
Nicardipine—CALM2—central nervous system—acquired immunodeficiency syndrome	0.000274	0.00375	CbGeAlD
Nicardipine—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000273	0.00374	CbGeAlD
Nicardipine—CHRM2—brain—acquired immunodeficiency syndrome	0.000272	0.00373	CbGeAlD
Nicardipine—CALM1—central nervous system—acquired immunodeficiency syndrome	0.000272	0.00373	CbGeAlD
Nicardipine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.00027	0.0037	CbGeAlD
Nicardipine—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000269	0.00368	CbGeAlD
Nicardipine—CALM3—lymph node—acquired immunodeficiency syndrome	0.000267	0.00366	CbGeAlD
Nicardipine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000267	0.00365	CbGeAlD
Nicardipine—CYP3A5—blood—acquired immunodeficiency syndrome	0.000262	0.00358	CbGeAlD
Nicardipine—CYP2B6—blood—acquired immunodeficiency syndrome	0.00026	0.00356	CbGeAlD
Nicardipine—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000259	0.00355	CbGeAlD
Nicardipine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000258	0.00353	CbGeAlD
Nicardipine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000257	0.00351	CbGeAlD
Nicardipine—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000256	0.00351	CbGeAlD
Nicardipine—CHRM1—brain—acquired immunodeficiency syndrome	0.000248	0.00339	CbGeAlD
Nicardipine—CYP2E1—blood—acquired immunodeficiency syndrome	0.000244	0.00334	CbGeAlD
Nicardipine—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000243	0.00332	CbGeAlD
Nicardipine—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000241	0.0033	CbGeAlD
Nicardipine—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000235	0.00322	CbGeAlD
Nicardipine—CYP3A5—lung—acquired immunodeficiency syndrome	0.00023	0.00314	CbGeAlD
Nicardipine—CYP2B6—lung—acquired immunodeficiency syndrome	0.000228	0.00312	CbGeAlD
Nicardipine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000226	0.00136	CcSEcCtD
Nicardipine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.00136	CcSEcCtD
Nicardipine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.00136	CcSEcCtD
Nicardipine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000226	0.00136	CcSEcCtD
Nicardipine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.00136	CcSEcCtD
Nicardipine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000225	0.00135	CcSEcCtD
Nicardipine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000225	0.00135	CcSEcCtD
Nicardipine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000225	0.00135	CcSEcCtD
Nicardipine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.00135	CcSEcCtD
Nicardipine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.00135	CcSEcCtD
Nicardipine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000224	0.00135	CcSEcCtD
Nicardipine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000224	0.00135	CcSEcCtD
Nicardipine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.00135	CcSEcCtD
Nicardipine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.00134	CcSEcCtD
Nicardipine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000223	0.00134	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000223	0.00134	CcSEcCtD
Nicardipine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000222	0.00133	CcSEcCtD
Nicardipine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.00133	CcSEcCtD
Nicardipine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.00133	CcSEcCtD
Nicardipine—CHRM3—brain—acquired immunodeficiency syndrome	0.000222	0.00304	CbGeAlD
Nicardipine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000222	0.00133	CcSEcCtD
Nicardipine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00133	CcSEcCtD
Nicardipine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.00133	CcSEcCtD
Nicardipine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00022	0.00132	CcSEcCtD
Nicardipine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.00132	CcSEcCtD
Nicardipine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00022	0.00132	CcSEcCtD
Nicardipine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00022	0.00132	CcSEcCtD
Nicardipine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00022	0.00132	CcSEcCtD
Nicardipine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000219	0.00131	CcSEcCtD
Nicardipine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000219	0.00131	CcSEcCtD
Nicardipine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000218	0.00131	CcSEcCtD
Nicardipine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.00131	CcSEcCtD
Nicardipine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.00131	CcSEcCtD
Nicardipine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000218	0.00131	CcSEcCtD
Nicardipine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000218	0.00131	CcSEcCtD
Nicardipine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000217	0.0013	CcSEcCtD
Nicardipine—CALM2—brain—acquired immunodeficiency syndrome	0.000217	0.00297	CbGeAlD
Nicardipine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.0013	CcSEcCtD
Nicardipine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.0013	CcSEcCtD
Nicardipine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.0013	CcSEcCtD
Nicardipine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.0013	CcSEcCtD
Nicardipine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000216	0.0013	CcSEcCtD
Nicardipine—CALM1—brain—acquired immunodeficiency syndrome	0.000216	0.00296	CbGeAlD
Nicardipine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.0013	CcSEcCtD
Nicardipine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000216	0.0013	CcSEcCtD
Nicardipine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000216	0.00129	CcSEcCtD
Nicardipine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000215	0.00129	CcSEcCtD
Nicardipine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000214	0.00129	CcSEcCtD
Nicardipine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.00129	CcSEcCtD
Nicardipine—CYP2E1—lung—acquired immunodeficiency syndrome	0.000214	0.00293	CbGeAlD
Nicardipine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.00129	CcSEcCtD
Nicardipine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00128	CcSEcCtD
Nicardipine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00128	CcSEcCtD
Nicardipine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00128	CcSEcCtD
Nicardipine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.00128	CcSEcCtD
Nicardipine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.00128	CcSEcCtD
Nicardipine—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000211	0.00289	CbGeAlD
Nicardipine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00127	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.00127	CcSEcCtD
Nicardipine—CALM2—lymph node—acquired immunodeficiency syndrome	0.00021	0.00287	CbGeAlD
Nicardipine—Pain—Indinavir—acquired immunodeficiency syndrome	0.00021	0.00126	CcSEcCtD
Nicardipine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00021	0.00126	CcSEcCtD
Nicardipine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.00126	CcSEcCtD
Nicardipine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00126	CcSEcCtD
Nicardipine—CALM1—lymph node—acquired immunodeficiency syndrome	0.000209	0.00286	CbGeAlD
Nicardipine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.00125	CcSEcCtD
Nicardipine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000208	0.00125	CcSEcCtD
Nicardipine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000208	0.00125	CcSEcCtD
Nicardipine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000208	0.00125	CcSEcCtD
Nicardipine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.00125	CcSEcCtD
Nicardipine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.00125	CcSEcCtD
Nicardipine—ABCB1—retina—acquired immunodeficiency syndrome	0.000208	0.00285	CbGeAlD
Nicardipine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000208	0.00125	CcSEcCtD
Nicardipine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000207	0.00125	CcSEcCtD
Nicardipine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.00124	CcSEcCtD
Nicardipine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.00124	CcSEcCtD
Nicardipine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.00124	CcSEcCtD
Nicardipine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.00124	CcSEcCtD
Nicardipine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.00124	CcSEcCtD
Nicardipine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000206	0.00282	CbGeAlD
Nicardipine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.00124	CcSEcCtD
Nicardipine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00124	CcSEcCtD
Nicardipine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00124	CcSEcCtD
Nicardipine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00124	CcSEcCtD
Nicardipine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.00123	CcSEcCtD
Nicardipine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.00123	CcSEcCtD
Nicardipine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000204	0.00123	CcSEcCtD
Nicardipine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.00122	CcSEcCtD
Nicardipine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000204	0.00279	CbGeAlD
Nicardipine—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000203	0.00278	CbGeAlD
Nicardipine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.00122	CcSEcCtD
Nicardipine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000203	0.00278	CbGeAlD
Nicardipine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.00122	CcSEcCtD
Nicardipine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000202	0.00121	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.00121	CcSEcCtD
Nicardipine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.00121	CcSEcCtD
Nicardipine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.00121	CcSEcCtD
Nicardipine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000201	0.00121	CcSEcCtD
Nicardipine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.00121	CcSEcCtD
Nicardipine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000201	0.0012	CcSEcCtD
Nicardipine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.0002	0.0012	CcSEcCtD
Nicardipine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.0012	CcSEcCtD
Nicardipine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.0012	CcSEcCtD
Nicardipine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.0002	0.0012	CcSEcCtD
Nicardipine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.0012	CcSEcCtD
Nicardipine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.00119	CcSEcCtD
Nicardipine—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000198	0.00271	CbGeAlD
Nicardipine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.00119	CcSEcCtD
Nicardipine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.00119	CcSEcCtD
Nicardipine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.00119	CcSEcCtD
Nicardipine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000198	0.00119	CcSEcCtD
Nicardipine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000198	0.00119	CcSEcCtD
Nicardipine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.00119	CcSEcCtD
Nicardipine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000198	0.00119	CcSEcCtD
Nicardipine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.00118	CcSEcCtD
Nicardipine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.00118	CcSEcCtD
Nicardipine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000197	0.00118	CcSEcCtD
Nicardipine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000196	0.00269	CbGeAlD
Nicardipine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.00118	CcSEcCtD
Nicardipine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.00118	CcSEcCtD
Nicardipine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.00118	CcSEcCtD
Nicardipine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.00118	CcSEcCtD
Nicardipine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.00118	CcSEcCtD
Nicardipine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.00117	CcSEcCtD
Nicardipine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.00117	CcSEcCtD
Nicardipine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.00117	CcSEcCtD
Nicardipine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000194	0.00116	CcSEcCtD
Nicardipine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000194	0.00116	CcSEcCtD
Nicardipine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000193	0.00116	CcSEcCtD
Nicardipine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000193	0.00265	CbGeAlD
Nicardipine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.00116	CcSEcCtD
Nicardipine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000193	0.00116	CcSEcCtD
Nicardipine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.00115	CcSEcCtD
Nicardipine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000192	0.00115	CcSEcCtD
Nicardipine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000192	0.00115	CcSEcCtD
Nicardipine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.00115	CcSEcCtD
Nicardipine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000191	0.00115	CcSEcCtD
Nicardipine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000191	0.00115	CcSEcCtD
Nicardipine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000191	0.00115	CcSEcCtD
Nicardipine—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000191	0.00261	CbGeAlD
Nicardipine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.00115	CcSEcCtD
Nicardipine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000191	0.00114	CcSEcCtD
Nicardipine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00019	0.00114	CcSEcCtD
Nicardipine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00019	0.00114	CcSEcCtD
Nicardipine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.00114	CcSEcCtD
Nicardipine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.00114	CcSEcCtD
Nicardipine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.00114	CcSEcCtD
Nicardipine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.00114	CcSEcCtD
Nicardipine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000189	0.00114	CcSEcCtD
Nicardipine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000188	0.00113	CcSEcCtD
Nicardipine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000188	0.00113	CcSEcCtD
Nicardipine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.00113	CcSEcCtD
Nicardipine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000187	0.00112	CcSEcCtD
Nicardipine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.00112	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.00112	CcSEcCtD
Nicardipine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000187	0.00112	CcSEcCtD
Nicardipine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.00111	CcSEcCtD
Nicardipine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.00111	CcSEcCtD
Nicardipine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.00111	CcSEcCtD
Nicardipine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.00111	CcSEcCtD
Nicardipine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.00111	CcSEcCtD
Nicardipine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000183	0.0011	CcSEcCtD
Nicardipine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000183	0.0011	CcSEcCtD
Nicardipine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.0011	CcSEcCtD
Nicardipine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.0011	CcSEcCtD
Nicardipine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.00109	CcSEcCtD
Nicardipine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.00109	CcSEcCtD
Nicardipine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.00109	CcSEcCtD
Nicardipine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000181	0.00109	CcSEcCtD
Nicardipine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000181	0.00109	CcSEcCtD
Nicardipine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.00108	CcSEcCtD
Nicardipine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00018	0.00108	CcSEcCtD
Nicardipine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00018	0.00108	CcSEcCtD
Nicardipine—CYP2C8—brain—acquired immunodeficiency syndrome	0.00018	0.00246	CbGeAlD
Nicardipine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.00108	CcSEcCtD
Nicardipine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.00107	CcSEcCtD
Nicardipine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000177	0.00107	CcSEcCtD
Nicardipine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.00106	CcSEcCtD
Nicardipine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000176	0.00106	CcSEcCtD
Nicardipine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.00106	CcSEcCtD
Nicardipine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.00106	CcSEcCtD
Nicardipine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.00105	CcSEcCtD
Nicardipine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.00105	CcSEcCtD
Nicardipine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.00105	CcSEcCtD
Nicardipine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.00105	CcSEcCtD
Nicardipine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.00105	CcSEcCtD
Nicardipine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.00105	CcSEcCtD
Nicardipine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.00104	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.00103	CcSEcCtD
Nicardipine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.00103	CcSEcCtD
Nicardipine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.00102	CcSEcCtD
Nicardipine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.00102	CcSEcCtD
Nicardipine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.00101	CcSEcCtD
Nicardipine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.00101	CcSEcCtD
Nicardipine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.00101	CcSEcCtD
Nicardipine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.00101	CcSEcCtD
Nicardipine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000168	0.00101	CcSEcCtD
Nicardipine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000168	0.00101	CcSEcCtD
Nicardipine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.00101	CcSEcCtD
Nicardipine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.001	CcSEcCtD
Nicardipine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000166	0.000998	CcSEcCtD
Nicardipine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.000998	CcSEcCtD
Nicardipine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000166	0.000998	CcSEcCtD
Nicardipine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000995	CcSEcCtD
Nicardipine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.000992	CcSEcCtD
Nicardipine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.000981	CcSEcCtD
Nicardipine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000976	CcSEcCtD
Nicardipine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000162	0.000974	CcSEcCtD
Nicardipine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000973	CcSEcCtD
Nicardipine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000973	CcSEcCtD
Nicardipine—CYP2B6—brain—acquired immunodeficiency syndrome	0.000161	0.00221	CbGeAlD
Nicardipine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000969	CcSEcCtD
Nicardipine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000967	CcSEcCtD
Nicardipine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000967	CcSEcCtD
Nicardipine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00016	0.00218	CbGeAlD
Nicardipine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.000955	CcSEcCtD
Nicardipine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.000952	CcSEcCtD
Nicardipine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000157	0.00215	CbGeAlD
Nicardipine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000157	0.000941	CcSEcCtD
Nicardipine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000937	CcSEcCtD
Nicardipine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000937	CcSEcCtD
Nicardipine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000156	0.000936	CcSEcCtD
Nicardipine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000932	CcSEcCtD
Nicardipine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000155	0.000929	CcSEcCtD
Nicardipine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000928	CcSEcCtD
Nicardipine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000924	CcSEcCtD
Nicardipine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000923	CcSEcCtD
Nicardipine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000154	0.0021	CbGeAlD
Nicardipine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.00092	CcSEcCtD
Nicardipine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000911	CcSEcCtD
Nicardipine—CYP2E1—brain—acquired immunodeficiency syndrome	0.000152	0.00207	CbGeAlD
Nicardipine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000151	0.00207	CbGeAlD
Nicardipine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000907	CcSEcCtD
Nicardipine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000894	CcSEcCtD
Nicardipine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000894	CcSEcCtD
Nicardipine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000148	0.00202	CbGeAlD
Nicardipine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.000885	CcSEcCtD
Nicardipine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000883	CcSEcCtD
Nicardipine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.00088	CcSEcCtD
Nicardipine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000877	CcSEcCtD
Nicardipine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000146	0.002	CbGeAlD
Nicardipine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000877	CcSEcCtD
Nicardipine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000146	0.000875	CcSEcCtD
Nicardipine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000873	CcSEcCtD
Nicardipine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000872	CcSEcCtD
Nicardipine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.00085	CcSEcCtD
Nicardipine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000846	CcSEcCtD
Nicardipine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000842	CcSEcCtD
Nicardipine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000839	CcSEcCtD
Nicardipine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000839	CcSEcCtD
Nicardipine—ABCB1—blood—acquired immunodeficiency syndrome	0.000139	0.0019	CbGeAlD
Nicardipine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000834	CcSEcCtD
Nicardipine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000833	CcSEcCtD
Nicardipine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.000826	CcSEcCtD
Nicardipine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000814	CcSEcCtD
Nicardipine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000811	CcSEcCtD
Nicardipine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000811	CcSEcCtD
Nicardipine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000135	0.00184	CbGeAlD
Nicardipine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000134	0.00183	CbGeAlD
Nicardipine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.000791	CcSEcCtD
Nicardipine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000784	CcSEcCtD
Nicardipine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000783	CcSEcCtD
Nicardipine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000776	CcSEcCtD
Nicardipine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000776	CcSEcCtD
Nicardipine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000129	0.00177	CbGeAlD
Nicardipine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000773	CcSEcCtD
Nicardipine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000771	CcSEcCtD
Nicardipine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000753	CcSEcCtD
Nicardipine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000748	CcSEcCtD
Nicardipine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000747	CcSEcCtD
Nicardipine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000746	CcSEcCtD
Nicardipine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000742	CcSEcCtD
Nicardipine—ABCB1—lung—acquired immunodeficiency syndrome	0.000122	0.00167	CbGeAlD
Nicardipine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000731	CcSEcCtD
Nicardipine—CYP2D6—brain—acquired immunodeficiency syndrome	0.00012	0.00164	CbGeAlD
Nicardipine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000719	CcSEcCtD
Nicardipine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000713	CcSEcCtD
Nicardipine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000712	CcSEcCtD
Nicardipine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000708	CcSEcCtD
Nicardipine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000704	CcSEcCtD
Nicardipine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000113	0.00155	CbGeAlD
Nicardipine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000671	CcSEcCtD
Nicardipine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000109	0.00149	CbGeAlD
Nicardipine—ABCB1—brain—acquired immunodeficiency syndrome	8.63e-05	0.00118	CbGeAlD
Nicardipine—ABCB1—lymph node—acquired immunodeficiency syndrome	8.34e-05	0.00114	CbGeAlD
Nicardipine—PDE1B—Disease—CD4—acquired immunodeficiency syndrome	1.45e-05	0.000319	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—IL2—acquired immunodeficiency syndrome	1.44e-05	0.000318	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.44e-05	0.000318	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.44e-05	0.000317	CbGpPWpGaD
Nicardipine—CALM2—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	1.43e-05	0.000317	CbGpPWpGaD
Nicardipine—CALM1—DAP12 interactions—IL6—acquired immunodeficiency syndrome	1.43e-05	0.000317	CbGpPWpGaD
Nicardipine—CALM2—DAP12 interactions—IL6—acquired immunodeficiency syndrome	1.43e-05	0.000317	CbGpPWpGaD
Nicardipine—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	1.43e-05	0.000317	CbGpPWpGaD
Nicardipine—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	1.43e-05	0.000317	CbGpPWpGaD
Nicardipine—CALM1—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	1.43e-05	0.000317	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.43e-05	0.000317	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.43e-05	0.000315	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.42e-05	0.000314	CbGpPWpGaD
Nicardipine—CALM2—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	1.42e-05	0.000314	CbGpPWpGaD
Nicardipine—CALM1—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	1.42e-05	0.000314	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.42e-05	0.000314	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.42e-05	0.000313	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.42e-05	0.000313	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.41e-05	0.000312	CbGpPWpGaD
Nicardipine—CALM1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	1.41e-05	0.000311	CbGpPWpGaD
Nicardipine—CALM2—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	1.41e-05	0.000311	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.41e-05	0.000311	CbGpPWpGaD
Nicardipine—CACNA1D—Metabolism—ALB—acquired immunodeficiency syndrome	1.41e-05	0.000311	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.41e-05	0.000311	CbGpPWpGaD
Nicardipine—CALM1—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	1.4e-05	0.00031	CbGpPWpGaD
Nicardipine—CALM2—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	1.4e-05	0.00031	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.4e-05	0.000309	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.4e-05	0.000308	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IFNA1—acquired immunodeficiency syndrome	1.38e-05	0.000305	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—ALB—acquired immunodeficiency syndrome	1.34e-05	0.000297	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CD79A—acquired immunodeficiency syndrome	1.34e-05	0.000296	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IFNA1—acquired immunodeficiency syndrome	1.34e-05	0.000295	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IFNA1—acquired immunodeficiency syndrome	1.34e-05	0.000295	CbGpPWpGaD
Nicardipine—CALM3—Disease—CXCR4—acquired immunodeficiency syndrome	1.33e-05	0.000294	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.32e-05	0.000291	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.31e-05	0.00029	CbGpPWpGaD
Nicardipine—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	1.31e-05	0.00029	CbGpPWpGaD
Nicardipine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.31e-05	0.00029	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.31e-05	0.000289	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—ALB—acquired immunodeficiency syndrome	1.3e-05	0.000287	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—ALB—acquired immunodeficiency syndrome	1.3e-05	0.000287	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.3e-05	0.000287	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CD79A—acquired immunodeficiency syndrome	1.3e-05	0.000287	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CD79A—acquired immunodeficiency syndrome	1.3e-05	0.000287	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.3e-05	0.000286	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.29e-05	0.000286	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.29e-05	0.000286	CbGpPWpGaD
Nicardipine—CALM2—Disease—CXCR4—acquired immunodeficiency syndrome	1.29e-05	0.000285	CbGpPWpGaD
Nicardipine—CALM1—Disease—CXCR4—acquired immunodeficiency syndrome	1.29e-05	0.000285	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.28e-05	0.000283	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.28e-05	0.000282	CbGpPWpGaD
Nicardipine—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	1.27e-05	0.000281	CbGpPWpGaD
Nicardipine—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	1.27e-05	0.000281	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.26e-05	0.000279	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.24e-05	0.000274	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.24e-05	0.000274	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.24e-05	0.000274	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.24e-05	0.000274	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—ALB—acquired immunodeficiency syndrome	1.24e-05	0.000273	CbGpPWpGaD
Nicardipine—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.22e-05	0.00027	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.21e-05	0.000267	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.2e-05	0.000265	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.19e-05	0.000263	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.19e-05	0.000263	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.18e-05	0.000262	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.18e-05	0.000261	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.17e-05	0.000259	CbGpPWpGaD
Nicardipine—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.17e-05	0.000259	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.17e-05	0.000259	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.16e-05	0.000257	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.16e-05	0.000257	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.14e-05	0.000253	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.14e-05	0.000253	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.14e-05	0.000251	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.13e-05	0.000251	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.12e-05	0.000247	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.12e-05	0.000247	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.12e-05	0.000247	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.11e-05	0.000246	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.11e-05	0.000246	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.11e-05	0.000245	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.1e-05	0.000244	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.1e-05	0.000244	CbGpPWpGaD
Nicardipine—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.1e-05	0.000243	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.1e-05	0.000243	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.1e-05	0.000243	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.1e-05	0.000242	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CD40LG—acquired immunodeficiency syndrome	1.09e-05	0.000242	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—IL2—acquired immunodeficiency syndrome	1.09e-05	0.000241	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.09e-05	0.00024	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.08e-05	0.000239	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CSF2—acquired immunodeficiency syndrome	1.08e-05	0.000239	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CD8A—acquired immunodeficiency syndrome	1.08e-05	0.000239	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.07e-05	0.000236	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.06e-05	0.000235	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.06e-05	0.000235	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.06e-05	0.000234	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.06e-05	0.000234	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CD40LG—acquired immunodeficiency syndrome	1.06e-05	0.000234	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CD40LG—acquired immunodeficiency syndrome	1.06e-05	0.000234	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—IL2—acquired immunodeficiency syndrome	1.05e-05	0.000233	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—IL2—acquired immunodeficiency syndrome	1.05e-05	0.000233	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.05e-05	0.000231	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.05e-05	0.000231	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CSF2—acquired immunodeficiency syndrome	1.05e-05	0.000231	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CD8A—acquired immunodeficiency syndrome	1.05e-05	0.000231	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CD8A—acquired immunodeficiency syndrome	1.05e-05	0.000231	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CSF2—acquired immunodeficiency syndrome	1.05e-05	0.000231	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HLA-B—acquired immunodeficiency syndrome	1.04e-05	0.00023	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.03e-05	0.000228	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.03e-05	0.000228	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.02e-05	0.000226	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.02e-05	0.000226	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.02e-05	0.000225	CbGpPWpGaD
Nicardipine—PDE1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.01e-05	0.000224	CbGpPWpGaD
Nicardipine—CALM3—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.01e-05	0.000223	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HLA-B—acquired immunodeficiency syndrome	1.01e-05	0.000222	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HLA-B—acquired immunodeficiency syndrome	1.01e-05	0.000222	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1e-05	0.000221	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.92e-06	0.000219	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	9.9e-06	0.000219	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	9.9e-06	0.000219	CbGpPWpGaD
Nicardipine—CALM2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	9.77e-06	0.000216	CbGpPWpGaD
Nicardipine—CALM1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	9.77e-06	0.000216	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.59e-06	0.000212	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.59e-06	0.000212	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.49e-06	0.00021	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.42e-06	0.000208	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.32e-06	0.000206	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.32e-06	0.000206	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.31e-06	0.000206	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.28e-06	0.000205	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.27e-06	0.000205	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—IL6—acquired immunodeficiency syndrome	9.26e-06	0.000205	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.14e-06	0.000202	CbGpPWpGaD
Nicardipine—CALM3—Disease—CCR5—acquired immunodeficiency syndrome	9.13e-06	0.000202	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.02e-06	0.000199	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.02e-06	0.000199	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.02e-06	0.000199	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.02e-06	0.000199	CbGpPWpGaD
Nicardipine—CALM1—Disease—CCR5—acquired immunodeficiency syndrome	8.83e-06	0.000195	CbGpPWpGaD
Nicardipine—CALM2—Disease—CCR5—acquired immunodeficiency syndrome	8.83e-06	0.000195	CbGpPWpGaD
Nicardipine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.81e-06	0.000195	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.66e-06	0.000191	CbGpPWpGaD
Nicardipine—PDE1A—Disease—IL6—acquired immunodeficiency syndrome	8.55e-06	0.000189	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.5e-06	0.000188	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.49e-06	0.000188	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.47e-06	0.000187	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—IL6—acquired immunodeficiency syndrome	8.47e-06	0.000187	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.39e-06	0.000185	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.37e-06	0.000185	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.37e-06	0.000185	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.35e-06	0.000184	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.3e-06	0.000183	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.26e-06	0.000183	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.25e-06	0.000182	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.24e-06	0.000182	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.22e-06	0.000182	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.14e-06	0.00018	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.12e-06	0.000179	CbGpPWpGaD
Nicardipine—PDE1B—Disease—IL6—acquired immunodeficiency syndrome	7.82e-06	0.000173	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.66e-06	0.000169	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.63e-06	0.000169	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.56e-06	0.000167	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.54e-06	0.000167	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.49e-06	0.000166	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.47e-06	0.000165	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.39e-06	0.000163	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.37e-06	0.000163	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.09e-06	0.000157	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.99e-06	0.000154	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.86e-06	0.000152	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.86e-06	0.000152	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.76e-06	0.000149	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.76e-06	0.000149	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.56e-06	0.000145	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.53e-06	0.000144	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	6.5e-06	0.000144	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IFNG—acquired immunodeficiency syndrome	6.43e-06	0.000142	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.39e-06	0.000141	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.28e-06	0.000139	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.25e-06	0.000138	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.25e-06	0.000138	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IFNG—acquired immunodeficiency syndrome	6.22e-06	0.000137	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IFNG—acquired immunodeficiency syndrome	6.22e-06	0.000137	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CD4—acquired immunodeficiency syndrome	6.21e-06	0.000137	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.18e-06	0.000137	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.18e-06	0.000137	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.05e-06	0.000134	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.05e-06	0.000134	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CD4—acquired immunodeficiency syndrome	6e-06	0.000133	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CD4—acquired immunodeficiency syndrome	6e-06	0.000133	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.99e-06	0.000132	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.91e-06	0.000131	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.88e-06	0.00013	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—IL6—acquired immunodeficiency syndrome	5.76e-06	0.000127	CbGpPWpGaD
Nicardipine—CALM3—Disease—CD4—acquired immunodeficiency syndrome	5.73e-06	0.000127	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL2—acquired immunodeficiency syndrome	5.71e-06	0.000126	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—ALB—acquired immunodeficiency syndrome	5.6e-06	0.000124	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—IL6—acquired immunodeficiency syndrome	5.58e-06	0.000123	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—IL6—acquired immunodeficiency syndrome	5.58e-06	0.000123	CbGpPWpGaD
Nicardipine—CALM2—Disease—CD4—acquired immunodeficiency syndrome	5.54e-06	0.000123	CbGpPWpGaD
Nicardipine—CALM1—Disease—CD4—acquired immunodeficiency syndrome	5.54e-06	0.000123	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL2—acquired immunodeficiency syndrome	5.52e-06	0.000122	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL2—acquired immunodeficiency syndrome	5.52e-06	0.000122	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	5.48e-06	0.000121	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.47e-06	0.000121	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	5.47e-06	0.000121	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—ALB—acquired immunodeficiency syndrome	5.45e-06	0.00012	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—ALB—acquired immunodeficiency syndrome	5.27e-06	0.000116	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—ALB—acquired immunodeficiency syndrome	5.27e-06	0.000116	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.9e-06	0.000108	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.88e-06	0.000108	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	4.74e-06	0.000105	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.42e-06	9.78e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.41e-06	9.75e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.4e-06	9.73e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.39e-06	9.7e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.37e-06	9.65e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.36e-06	9.63e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.35e-06	9.6e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.33e-06	9.58e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	4.23e-06	9.34e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	4.13e-06	9.12e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.89e-06	8.59e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.86e-06	8.52e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	3.86e-06	8.52e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.69e-06	8.16e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.69e-06	8.16e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.67e-06	8.12e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.57e-06	7.89e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.57e-06	7.89e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.55e-06	7.85e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.55e-06	7.85e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.47e-06	7.67e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—acquired immunodeficiency syndrome	3.36e-06	7.42e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—acquired immunodeficiency syndrome	3.25e-06	7.18e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—acquired immunodeficiency syndrome	3.25e-06	7.18e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—acquired immunodeficiency syndrome	3.1e-06	6.85e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—acquired immunodeficiency syndrome	3e-06	6.63e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—acquired immunodeficiency syndrome	3e-06	6.63e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.88e-06	6.37e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.6e-06	5.75e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.59e-06	5.73e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.57e-06	5.67e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.56e-06	5.66e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.54e-06	5.62e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.17e-06	4.8e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.1e-06	4.64e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.1e-06	4.64e-05	CbGpPWpGaD
